LEXX - Lexaria stock rallies 20% on positive GLP-1 drug delivery study
2023-11-27 12:12:40 ET
More on Lexaria Bioscience Corp.
- Lexaria Bioscience enters license agreement with SulfoSyn
- Lexaria Bioscience enters into securities purchase agreement
- Seeking Alpha’s Quant Rating on Lexaria Bioscience Corp.
- Historical earnings data for Lexaria Bioscience Corp.
- Financial information for Lexaria Bioscience Corp.
For further details see:
Lexaria stock rallies 20% on positive GLP-1 drug delivery study